Kahn P C, Milunsky C, Dewanjee M K, Rudders R A
AJR Am J Roentgenol. 1977 Aug;129(2):267-73. doi: 10.2214/ajr.129.2.267.
The clinical records and imaging studies of 140 patients who had 57Co-bleomycin scans were reviewed. In 53% of the patients with known tumor at the time of examination, all clinically demonstrable lesions picked up cobalt. The success rate was particularly high in carcinoma of the lung (15 of 17) and gastrointestinal tract (12 of 17). The major role of cobalt bleomycin seems to be as an early screening test for metastases in patients with carcinoma of the lung, gastrointestinal tract, and uterus. The scan is most useful in demonstrating spread to the brain, liver, and adrenals.
对140例接受过57钴-博来霉素扫描的患者的临床记录和影像学研究进行了回顾。在检查时已知患有肿瘤的患者中，53%的患者所有临床可显示的病变都摄取了钴。在肺癌（17例中的15例）和胃肠道癌（17例中的12例）中成功率尤其高。钴博来霉素的主要作用似乎是作为肺癌、胃肠道癌和子宫癌患者转移灶的早期筛查试验。该扫描在显示转移至脑、肝和肾上腺方面最有用。
